TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment
Clinical trial NCT04951050 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04951050
- Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2023-08-26
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.